BrainsWay announced its broad market entry into Canada for the Company’s proprietary Deep Transcranial Magnetic Stimulation system through the signing of an exclusive multi-year distribution agreement with a specialty distributor serving both the acute hospital and non-acute healthcare spaces via a team of over 35 sales professionals and a portfolio of products across a range of clinical categories. The agreement includes minimum quantity orders which increase successively over several years, starting with 11 Deep TMS systems to be ordered in 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BWAY:
- BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada
- BrainsWay Tests Accelerated Depression Treatment
- BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression
- Brainsway launches trial evaluating accelerated Deep TMS for depression
- BrainsWay Secures FDA Nod for Elderly Depression Treatment